FOXO Subsidiary Vector Biosource Acquires Four Blood Centers
FOXO Technologies Inc.'s subsidiary Vector Biosource announced the acquisition of four US blood collection centers to source bio-products and expand market access. Closing is required by 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day